Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Stroke

  Free Subscription


Articles published in Eur Heart J

Retrieve available abstracts of 224 articles:
HTML format



Single Articles


    September 2021
  1. OYAMA K, Giugliano RP, Tang M, Bonaca MP, et al
    Effect of evolocumab on acute arterial events across all vascular territories : results from the FOURIER trial.
    Eur Heart J. 2021 Sep 19. pii: 6372436. doi: 10.1093.
    PubMed     Abstract available


  2. LOPEZ-SENDON JL, Cyr DD, Mark DB, Bangalore S, et al
    Effects of initial invasive vs. initial conservative treatment strategies on recurrent and total cardiovascular events in the ISCHEMIA trial.
    Eur Heart J. 2021 Sep 13. pii: 6368943. doi: 10.1093.
    PubMed     Abstract available


  3. DEFILIPPIS AP, Trainor PJ, Thanassoulis G, Brumback LC, et al
    Atherothrombotic factors and atherosclerotic cardiovascular events: the multi-ethnic study of atherosclerosis.
    Eur Heart J. 2021 Sep 11. pii: 6368900. doi: 10.1093.
    PubMed     Abstract available


  4. KANG EH, Park EH, Shin A, Song JS, et al
    Cardiovascular risk associated with allopurinol vs. benzbromarone in patients with gout.
    Eur Heart J. 2021 Sep 11. pii: 6368678. doi: 10.1093.
    PubMed     Abstract available


  5. PETERSEN JK, Haider Butt J, Yafasova A, Torp-Pedersen C, et al
    Incidence of ischaemic stroke and mortality in patients with acute coronary syndrome and first-time detected atrial fibrillation: a nationwide study.
    Eur Heart J. 2021 Sep 3. pii: 6363625. doi: 10.1093.
    PubMed     Abstract available


  6. GINSBERG HN, Packard CJ, Chapman MJ, Boren J, et al
    Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society.
    Eur Heart J. 2021 Sep 2. pii: 6362485. doi: 10.1093.
    PubMed     Abstract available


  7. BONNESEN MP, Frodi DM, Haugan KJ, Kronborg C, et al
    Day-to-day measurement of physical activity and risk of atrial fibrillation.
    Eur Heart J. 2021 Sep 2. pii: 6362464. doi: 10.1093.
    PubMed     Abstract available


    August 2021
  8. KRANTZ MJ, Debus SE, Hsia J, Patel MR, et al
    Low-dose rivaroxaban plus aspirin in older patients with peripheral artery disease undergoing acute limb revascularization: insights from the VOYAGER PAD trial.
    Eur Heart J. 2021 Aug 25. pii: 6357238. doi: 10.1093.
    PubMed     Abstract available


  9. STEFANINI GG, Briguori C, Cao D, Baber U, et al
    Ticagrelor monotherapy in patients with chronic kidney disease undergoing percutaneous coronary intervention: TWILIGHT-CKD.
    Eur Heart J. 2021 Aug 23. pii: 6356261. doi: 10.1093.
    PubMed     Abstract available


  10. ZEYMER U, Ludman P, Danchin N, Kala P, et al
    Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in Europe: the ACVC-EAPCI EORP STEMI Registry of the European Society of Cardiology.
    Eur Heart J. 2021 Aug 14. pii: 6352178. doi: 10.1093.
    PubMed     Abstract available


  11. BECATTINI C, Cimini LA, Agnelli G
    Home management or hospital admission for low-risk pulmonary embolism? Clinical scores versus pragmatic assessment.
    Eur Heart J. 2021 Aug 13. pii: 6350777. doi: 10.1093.
    PubMed    


  12. HAN Y, Hu Y, Yu C, Guo Y, et al
    Lifestyle, cardiometabolic disease, and multimorbidity in a prospective Chinese study.
    Eur Heart J. 2021 Aug 1. pii: 6333295. doi: 10.1093.
    PubMed     Abstract available


  13. ROMITI GF, Corica B, Pipitone E, Vitolo M, et al
    Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: a systematic review and meta-analysis of 4,200,000 patients.
    Eur Heart J. 2021 Aug 1. pii: 6333297. doi: 10.1093.
    PubMed     Abstract available


  14. KIM MS, Kim WJ, Khera AV, Kim JY, et al
    Association between adiposity and cardiovascular outcomes: an umbrella review and meta-analysis of observational and Mendelian randomization studies.
    Eur Heart J. 2021 Aug 1. pii: 6333298. doi: 10.1093.
    PubMed     Abstract available


    July 2021
  15. KOSYAKOVSKY LB, Austin PC, Ross HJ, Wang X, et al
    Early invasive coronary angiography and acute ischaemic heart failure outcomes.
    Eur Heart J. 2021 Jul 30. pii: 6331345. doi: 10.1093.
    PubMed     Abstract available


  16. TOOROP MMA, Chen Q, Tichelaar VYIG, Cannegieter SC, et al
    Predictors, time course, and outcomes of persistence patterns in oral anticoagulation for non-valvular atrial fibrillation: a Dutch Nationwide Cohort Study.
    Eur Heart J. 2021 Jul 16. pii: 6322389. doi: 10.1093.
    PubMed     Abstract available



  17. SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions.
    Eur Heart J. 2021;42:2455-2467.
    PubMed     Abstract available


    June 2021
  18. BECATTINI C, Maraziti G, Vinson DR, Ng ACC, et al
    Right ventricle assessment in patients with pulmonary embolism at low risk for death based on clinical models: an individual patient data meta-analysis.
    Eur Heart J. 2021 Jun 28. pii: 6310284. doi: 10.1093.
    PubMed     Abstract available


  19. HE FJ, Campbell NRC, Woodward M, MacGregor GA, et al
    Salt reduction to prevent hypertension: the reasons of the controversy.
    Eur Heart J. 2021 Jun 12. pii: 6297147. doi: 10.1093.
    PubMed     Abstract available


  20. LEE SR, Choi EK, Jung JH, Han KD, et al
    Lower risk of stroke after alcohol abstinence in patients with incident atrial fibrillation: a nationwide population-based cohort study.
    Eur Heart J. 2021 Jun 7. pii: 6294435. doi: 10.1093.
    PubMed     Abstract available


  21. CREA F
    Dyslipidaemias in stroke, chronic kidney disease, and aortic stenosis: the new frontiers for cholesterol lowering.
    Eur Heart J. 2021;42:2137-2140.
    PubMed    


  22. TSIMIKAS S
    Elevated lipoprotein(a) and the risk of stroke in children, young adults, and the elderly.
    Eur Heart J. 2021;42:2197-2200.
    PubMed    


    May 2021
  23. KHURSHID S, Weng LC, Al-Alusi MA, Halford JL, et al
    Accelerometer-derived physical activity and risk of atrial fibrillation.
    Eur Heart J. 2021 May 25. pii: 6283622. doi: 10.1093.
    PubMed     Abstract available


  24. LANSKY AJ, Makkar R, Nazif T, Messe S, et al
    A randomized evaluation of the TriGuard HDH cerebral embolic protection device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation: the REFLECT I trial.
    Eur Heart J. 2021 May 17. pii: 6277114. doi: 10.1093.
    PubMed     Abstract available


  25. CREA F
    New challenges in vascular biology and medicine: from unravelling the mechanisms of neointima formation to the prevention of amputations and of ischaemic stroke.
    Eur Heart J. 2021;42:1715-1719.
    PubMed    


  26. IMAZIO M, Nidorf M
    Colchicine and the heart.
    Eur Heart J. 2021 May 7. pii: 6271392. doi: 10.1093.
    PubMed     Abstract available


  27. KROHN-GRIMBERGHE M, Duerschmied D, Bode C
    What do we learn by repeating the ABC?
    Eur Heart J. 2021;42:1707-1709.
    PubMed    


    April 2021
  28. BRIEGER D, Freedman B
    Decoding stroke risk scores in atrial fibrillation: still more work to do.
    Eur Heart J. 2021 Apr 6. pii: 6213361. doi: 10.1093/eurheartj/ehaa1111.
    PubMed    


    March 2021
  29. DE JONG Y, Fu EL, van Diepen M, Trevisan M, et al
    Validation of risk scores for ischaemic stroke in atrial fibrillation across the spectrum of kidney function.
    Eur Heart J. 2021 Mar 26. pii: 6188994. doi: 10.1093.
    PubMed     Abstract available


  30. FIOLET ATL, Opstal TSJ, Mosterd A, Eikelboom JW, et al
    Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials.
    Eur Heart J. 2021 Mar 26. pii: 6188997. doi: 10.1093.
    PubMed     Abstract available


  31. AJJAN RA, Kietsiriroje N, Badimon L, Vilahur G, et al
    Antithrombotic therapy in diabetes: which, when, and for how long?
    Eur Heart J. 2021 Mar 25. pii: 6186730. doi: 10.1093.
    PubMed     Abstract available


  32. OYAMA K, Giugliano RP, Berg DD, Ruff CT, et al
    Serial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial.
    Eur Heart J. 2021 Mar 24. pii: 6184829. doi: 10.1093.
    PubMed     Abstract available


  33. ARNOLD M, Schweizer J, Nakas CT, Schutz V, et al
    Lipoprotein(a) is associated with large artery atherosclerosis stroke aetiology and stroke recurrence among patients below the age of 60 years: results from the BIOSIGNAL study.
    Eur Heart J. 2021 Mar 8. pii: 6168588. doi: 10.1093.
    PubMed     Abstract available


  34. REED GW, Krishnaswamy A, Kapadia SR
    Silent brain infarction after TAVR: common but of unclear significance.
    Eur Heart J. 2021;42:1016-1018.
    PubMed    


    February 2021
  35. BUTT JH, Fosbol EL, Gerds TA, Andersson C, et al
    All-cause mortality and location of death in patients with established cardiovascular disease before, during, and after the COVID-19 lockdown: a Danish Nationwide Cohort Study.
    Eur Heart J. 2021 Feb 24. pii: 6149000. doi: 10.1093.
    PubMed     Abstract available


  36. WOLDENDORP K, Indja B, Bannon PG, Fanning JP, et al
    Silent brain infarcts and early cognitive outcomes after transcatheter aortic valve implantation: a systematic review and meta-analysis.
    Eur Heart J. 2021 Feb 1. pii: 6124789. doi: 10.1093.
    PubMed     Abstract available


    January 2021
  37. SEMERANO A, Saliou G, Sanvito F, Genchi A, et al
    Fishing an anemone in the brain: embolized cardiac fibroelastoma revealed after stroke thrombectomy.
    Eur Heart J. 2021 Jan 31. pii: 6124843. doi: 10.1093.
    PubMed    


  38. PRISTIPINO C, Germonpre P, Toni D, Sievert H, et al
    European position paper on the management of patients with patent foramen ovale. Part II - Decompression sickness, migraine, arterial deoxygenation syndromes and select high-risk clinical conditions.
    Eur Heart J. 2021 Jan 28. pii: 6122426. doi: 10.1093/eurheartj/ehaa1070.
    PubMed     Abstract available


  39. RIENSTRA M, Van Gelder IC
    Incidence and outcome of atrial fibrillation: diversity throughout Europe.
    Eur Heart J. 2021 Jan 25. pii: 6120041. doi: 10.1093/eurheartj/ehaa1078.
    PubMed    



  40. Corrigendum to: Interdisciplinary management of acute ischaemic stroke: Current evidence training requirements for endovascular stroke treatment: Position Paper from the ESC Council on Stroke and the European Association for Percutaneous Cardiovascula
    Eur Heart J. 2021;42:307.
    PubMed    


  41. NARDAI S, Lanzer P, Abelson M, Baumbach A, et al
    Interdisciplinary management of acute ischaemic stroke: Current evidence training requirements for endovascular stroke treatment: Position Paper from the ESC Council on Stroke and the European Association for Percutaneous Cardiovascular Interventions
    Eur Heart J. 2021;42:298-307.
    PubMed     Abstract available


  42. CREA F
    Management of ischaemic stroke, prognostic impact of procedural myocardial injury, and antiplatelet treatment: the many facets of interventional cardiology.
    Eur Heart J. 2021;42:289-291.
    PubMed    


    December 2020
  43. SCHUBERT J, Lindahl B, Melhus H, Renlund H, et al
    Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes: a Swedish nationwide cohort study.
    Eur Heart J. 2020 Dec 24. pii: 6047259. doi: 10.1093/eurheartj/ehaa1011.
    PubMed     Abstract available


  44. PETERMANN-ROCHA F, Parra-Soto S, Gray S, Anderson J, et al
    Vegetarians, fish, poultry, and meat-eaters: who has higher risk of cardiovascular disease incidence and mortality? A prospective study from UK Biobank.
    Eur Heart J. 2020 Dec 14. pii: 6032616. doi: 10.1093.
    PubMed     Abstract available


    November 2020
  45. NARDAI S, Lanzer P, Abelson M, Baumbach A, et al
    Interdisciplinary management of acute ischaemic stroke: Current evidence training requirements for endovascular stroke treatment.
    Eur Heart J. 2020 Nov 7. pii: 5960214. doi: 10.1093.
    PubMed     Abstract available


  46. NANJO A, Evans H, Direk K, Hayward AC, et al
    Prevalence, incidence, and outcomes across cardiovascular diseases in homeless individuals using national linked electronic health records.
    Eur Heart J. 2020;41:4011-4020.
    PubMed     Abstract available


    October 2020
  47. LIUZZO G, Patrono C
    Low-Dose Edoxaban for Stroke Prevention in Elderly Patients with Atrial Fibrillation: Comment on the Edoxaban Low-Dose for Elder Care Atrial Fibrillation Patients (ELDERCARE-AF) Trial.
    Eur Heart J. 2020 Oct 17. pii: 5927543. doi: 10.1093.
    PubMed    


    September 2020
  48. WALLENTIN L, Lindback J, Eriksson N, Hijazi Z, et al
    Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation.
    Eur Heart J. 2020 Sep 27. pii: 5912214. doi: 10.1093.
    PubMed     Abstract available


  49. LIBBY P, Luscher T
    COVID-19 is, in the end, an endothelial disease.
    Eur Heart J. 2020;41:3038-3044.
    PubMed     Abstract available


    August 2020
  50. VRANCKX P, Valgimigli M, Eckardt L, Lewalter T, et al
    Edoxaban in atrial fibrillation patients with percutaneous coronary intervention by acute or chronic coronary syndrome presentation: a pre-specified analysis of the ENTRUST-AF PCI trial.
    Eur Heart J. 2020 Aug 29. pii: 5898835. doi: 10.1093.
    PubMed     Abstract available


  51. BOUABDALLAOUI N, Tardif JC, Waters DD, Pinto FJ, et al
    Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT).
    Eur Heart J. 2020 Aug 29. pii: 5898840. doi: 10.1093.
    PubMed     Abstract available


  52. HINDRICKS G, Potpara T, Dagres N, Arbelo E, et al
    2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS).
    Eur Heart J. 2020 Aug 29. pii: 5899003. doi: 10.1093.
    PubMed    


  53. TUNON J, Steg PG, Bhatt DL, Bittner VA, et al
    Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome: prespecified analysis from the ODYSSEY OUTCOMES randomized clinical trial.
    Eur Heart J. 2020 Aug 21. pii: 5895197. doi: 10.1093.
    PubMed     Abstract available


  54. FERLINI M, Mauri S
    Variable rate of stroke after transcatheter aortic valve replacement with self-expandable valves: more doubts than certainties.
    Eur Heart J. 2020 Aug 18. pii: 5893661. doi: 10.1093.
    PubMed    


  55. THIELE H, Abdel-Wahab M, Desch S
    Stroke rates after transcatheter aortic valve replacement: does valve choice play a role?
    Eur Heart J. 2020 Aug 18. pii: 5893660. doi: 10.1093.
    PubMed    


    July 2020
  56. MENTE A, Dehghan M, Yusuf S
    Diet and health: the need for new and reliable approaches.
    Eur Heart J. 2020;41:2641-2644.
    PubMed    


    June 2020
  57. HOLT A, Gislason GH, Schou M, Zareini B, et al
    New-onset atrial fibrillation: incidence, characteristics, and related events following a national COVID-19 lockdown of 5.6 million people.
    Eur Heart J. 2020 Jun 24. pii: 5861973. doi: 10.1093.
    PubMed     Abstract available


    May 2020
  58. SCHMIADY MO, Sromicki J, Kucher N, Ouda A, et al
    Successful percutaneous thrombectomy in a patient with COVID-19 pneumonia and acute pulmonary embolism supported by extracorporeal membrane oxygenation.
    Eur Heart J. 2020 May 12. pii: 5836253. doi: 10.1093.
    PubMed    


    April 2020
  59. LIAO B, Geng L, Zhang F, Shu L, et al
    Adipocyte fatty acid-binding protein exacerbates cerebral ischaemia injury by disrupting the blood-brain barrier.
    Eur Heart J. 2020 Apr 29. pii: 5827043. doi: 10.1093.
    PubMed     Abstract available


  60. BACIGALUPPI M, Martino G
    FABP4 a novel therapeutic target in ischaemic stroke.
    Eur Heart J. 2020 Apr 29. pii: 5827052. doi: 10.1093.
    PubMed    


  61. NTAIOS G, Wintermark M, Michel P
    Supracardiac atherosclerosis in embolic stroke of undetermined source: the underestimated source.
    Eur Heart J. 2020 Apr 16. pii: 5821054. doi: 10.1093.
    PubMed     Abstract available


  62. LARSSON SC, Mason AM, Back M, Klarin D, et al
    Genetic predisposition to smoking in relation to 14 cardiovascular diseases.
    Eur Heart J. 2020 Apr 16. pii: 5821049. doi: 10.1093.
    PubMed     Abstract available


  63. LINDE C
    Integrated care for atrial fibrillation: time for widespread use.
    Eur Heart J. 2020 Apr 13. pii: 5819644. doi: 10.1093.
    PubMed    


  64. HILDICK-SMITH D, Landmesser U, Camm AJ, Diener HC, et al
    Left atrial appendage occlusion with the Amplatzer Amulet device: full results of the prospective global observational study.
    Eur Heart J. 2020 Apr 3. pii: 5815608. doi: 10.1093.
    PubMed     Abstract available


    March 2020
  65. MOUSSA O, Ardissino M, Heaton T, Tang A, et al
    Effect of bariatric surgery on long-term cardiovascular outcomes: a nationwide nested cohort study.
    Eur Heart J. 2020 Mar 19. pii: 5809084. doi: 10.1093.
    PubMed     Abstract available


    February 2020
  66. TONG TYN, Appleby PN, Key TJ, Dahm CC, et al
    The associations of major foods and fibre with risks of ischaemic and haemorrhagic stroke: a prospective study of 418 329 participants in the EPIC cohort across nine European countries.
    Eur Heart J. 2020 Feb 24. pii: 5748325. doi: 10.1093.
    PubMed     Abstract available


  67. GARNVIK LE, Malmo V, Janszky I, Ellekjaer H, et al
    Physical activity, cardiorespiratory fitness, and cardiovascular outcomes in individuals with atrial fibrillation: the HUNT study.
    Eur Heart J. 2020 Feb 11. pii: 5733768. doi: 10.1093.
    PubMed     Abstract available


  68. HUANG HK, Liu PP, Hsu JY, Lin SM, et al
    Fracture risks among patients with atrial fibrillation receiving different oral anticoagulants: a real-world nationwide cohort study.
    Eur Heart J. 2020 Feb 1. pii: 5718429. doi: 10.1093.
    PubMed     Abstract available


    December 2019
  69. MALMBORG M, Schmiegelow MDS, Norgaard CH, Munch A, et al
    Does type 2 diabetes confer higher relative rates of cardiovascular events in women compared with men?
    Eur Heart J. 2019 Dec 20. pii: 5682397. doi: 10.1093.
    PubMed     Abstract available


  70. GUNDLUND A, Olesen JB, Butt JH, Christensen MA, et al
    One-year outcomes in atrial fibrillation presenting during infections: a nationwide registry-based study.
    Eur Heart J. 2019 Dec 17. pii: 5680017. doi: 10.1093.
    PubMed     Abstract available


  71. JONES NR, Taylor CJ, Hobbs FDR, Bowman L, et al
    Screening for atrial fibrillation: a call for evidence.
    Eur Heart J. 2019 Dec 7. pii: 5663566. doi: 10.1093.
    PubMed     Abstract available


  72. BHARADWAJ A, Potts J, Mohamed MO, Parwani P, et al
    Acute myocardial infarction treatments and outcomes in 6.5 million patients with a current or historical diagnosis of cancer in the USA.
    Eur Heart J. 2019 Dec 4. pii: 5652220. doi: 10.1093.
    PubMed     Abstract available


    November 2019
  73. LUSCHER TF
    Optimizing heart failure management: anticoagulation, diuretic withdrawal, iron substitution, and novel inotropes.
    Eur Heart J. 2019;40:3579-3582.
    PubMed    


  74. SINNAEVE PR, Schwartz GG, Wojdyla DM, Alings M, et al
    Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an ODYSSEY OUTCOMES trial analysis.
    Eur Heart J. 2019 Nov 16. pii: 5626150. doi: 10.1093.
    PubMed     Abstract available


    October 2019
  75. GARGIULO G, Goette A, Tijssen J, Eckardt L, et al
    Safety and efficacy outcomes of double vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulant-based rand
    Eur Heart J. 2019 Oct 25. pii: 5607287. doi: 10.1093.
    PubMed     Abstract available


  76. IBANEZ B
    And fibrinolysis became pharmacoinvasive.
    Eur Heart J. 2019 Oct 12. pii: 5586502. doi: 10.1093.
    PubMed    


  77. LIBERALE L, Gaul DS, Akhmedov A, Bonetti NR, et al
    Endothelial SIRT6 blunts stroke size and neurological deficit by preserving blood-brain barrier integrity: a translational study.
    Eur Heart J. 2019 Oct 11. pii: 5585651. doi: 10.1093.
    PubMed     Abstract available


    September 2019
  78. WIJTVLIET EPJP, Tieleman RG, van Gelder IC, Pluymaekers NAHA, et al
    Nurse-led vs. usual-care for atrial fibrillation.
    Eur Heart J. 2019 Sep 23. pii: 5572602. doi: 10.1093.
    PubMed     Abstract available


  79. GUHA A, Dey AK, Jneid H, Ibarz JP, et al
    Atrial Fibrillation in the Era of Emerging Cancer Therapies.
    Eur Heart J. 2019;40:3007-3010.
    PubMed    


  80. SULZGRUBER P, Wassmann S, Semb AG, Doehner W, et al
    Oral Anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1.
    Eur Heart J. 2019;40:3010-3012.
    PubMed    


  81. DANCHIN N, Popovic B, Puymirat E, Goldstein P, et al
    Five-year outcomes following timely primary percutaneous intervention, late primary percutaneous intervention, or a pharmaco-invasive strategy in ST-segment elevation myocardial infarction: the FAST-MI programme.
    Eur Heart J. 2019 Sep 20. pii: 5572227. doi: 10.1093.
    PubMed     Abstract available


  82. POTPARA T, Steffel J
    Strategies in patients with atrial fibrillation taking non-vitamin K antagonist oral anticoagulants (NOACs) and co-medications with possible drug-drug interaction.
    Eur Heart J. 2019 Sep 20. pii: 5572224. doi: 10.1093.
    PubMed    


  83. THRANE PG, Kristensen SD, Olesen KKW, Mortensen LS, et al
    16-year follow-up of the Danish Acute Myocardial Infarction 2 (DANAMI-2) trial: primary percutaneous coronary intervention vs. fibrinolysis in ST-segment elevation myocardial infarction.
    Eur Heart J. 2019 Sep 2. pii: 5554441. doi: 10.1093.
    PubMed     Abstract available


    August 2019
  84. SERRUYS PW, Takahashi K, Chichareon P, Kogame N, et al
    Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trial.
    Eur Heart J. 2019;40:2595-2604.
    PubMed     Abstract available


  85. MAGGIONI AP, Andreotti F
    Stroke prevention by low-dose anticoagulation in patients with heart failure and sinus rhythm: is it worth the effort?
    Eur Heart J. 2019 Aug 1. pii: 5542639. doi: 10.1093.
    PubMed    


    July 2019
  86. LOMAKIN NV, Buryachkovskaya LI, Shirokov EA, Vitko NK, et al
    Evgeny Chazov: first thrombolysis for ischaemic stroke.
    Eur Heart J. 2019;40:2281-2283.
    PubMed    


  87. KUHNE M, Krisai P, Conen D, Osswald S, et al
    The heart-brain connection: further establishing the relationship between atrial fibrillation and dementia?
    Eur Heart J. 2019;40:2324-2326.
    PubMed    


  88. KILLU AM, Gersh BJ
    Response to: Risk stratification for stroke in atrial fibrillation: incorporating neurologists in the comprehensive management.
    Eur Heart J. 2019 Jul 13. pii: 5532107. doi: 10.1093.
    PubMed    


  89. LI HF, Liang B, Li HY
    Risk stratification for stroke in atrial fibrillation: incorporating neurologists in the comprehensive management.
    Eur Heart J. 2019 Jul 13. pii: 5532108. doi: 10.1093.
    PubMed    


  90. GUEDENEY P, Giustino G, Sorrentino S, Claessen BE, et al
    Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials.
    Eur Heart J. 2019 Jul 3. pii: 5527995. doi: 10.1093.
    PubMed     Abstract available


    June 2019
  91. MEHRA MR, Vaduganathan M, Fu M, Ferreira JP, et al
    A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial
    Eur Heart J. 2019 Jun 25. pii: 5522950. doi: 10.1093.
    PubMed     Abstract available


  92. KOTECHA D, Castella M
    Is it time to treat post-operative atrial fibrillation just like regular atrial fibrillation?
    Eur Heart J. 2019 Jun 25. pii: 5523037. doi: 10.1093.
    PubMed    


  93. CONEN D, Alonso-Coello P, Douketis J, Chan MTV, et al
    Risk of stroke and other adverse outcomes in patients with perioperative atrial fibrillation 1 year after non-cardiac surgery.
    Eur Heart J. 2019 Jun 25. pii: 5523034. doi: 10.1093.
    PubMed     Abstract available


  94. PIAZZA G, Hurwitz S, Galvin CE, Harrigan L, et al
    Alert-based computerized decision support for high-risk hospitalized patients with atrial fibrillation not prescribed anticoagulation: a randomized, controlled trial (AF-ALERT).
    Eur Heart J. 2019 Jun 22. pii: 5521151. doi: 10.1093.
    PubMed     Abstract available


  95. DEMEESTERE J, Lemmens R
    Anticoagulation in low-risk patients with atrial fibrillation: beyond prevention of ischaemic stroke.
    Eur Heart J. 2019 Jun 18. pii: 5519990. doi: 10.1093.
    PubMed    


  96. KIM D, Yang PS, Yu HT, Kim TH, et al
    Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a population-based cohort.
    Eur Heart J. 2019 Jun 18. pii: 5520105. doi: 10.1093.
    PubMed     Abstract available


  97. LARSSON SC, Back M, Rees JMB, Mason AM, et al
    Body mass index and body composition in relation to 14 cardiovascular conditions in UK Biobank: a Mendelian randomization study.
    Eur Heart J. 2019 Jun 13. pii: 5514076. doi: 10.1093.
    PubMed     Abstract available


    May 2019
  98. KELLER K, Hobohm L, Ebner M, Kresoja KP, et al
    Trends in thrombolytic treatment and outcomes of acute pulmonary embolism in Germany.
    Eur Heart J. 2019 May 18. pii: 5490731. doi: 10.1093.
    PubMed     Abstract available


  99. FRIBERG L, Andersson T, Rosenqvist M
    Less dementia and stroke in low-risk patients with atrial fibrillation taking oral anticoagulation.
    Eur Heart J. 2019 May 16. pii: 5490291. doi: 10.1093.
    PubMed     Abstract available


    April 2019
  100. HOHNLOSER SH, Camm J, Cappato R, Diener HC, et al
    Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial.
    Eur Heart J. 2019 Apr 11. pii: 5446017. doi: 10.1093.
    PubMed     Abstract available


  101. BONDE AN, Blanche P, Staerk L, Gerds TA, et al
    Oral anticoagulation among atrial fibrillation patients with anaemia: an observational cohort study.
    Eur Heart J. 2019 Apr 1. pii: 5424120. doi: 10.1093.
    PubMed     Abstract available


    March 2019
  102. NOSEWORTHY PA, Gersh BJ, Kent DM, Piccini JP, et al
    Atrial fibrillation ablation in practice: assessing CABANA generalizability.
    Eur Heart J. 2019 Mar 15. pii: 5381200. doi: 10.1093.
    PubMed     Abstract available


    February 2019
  103. OLDGREN J, Steg PG, Hohnloser SH, Lip GYH, et al
    Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial.
    Eur Heart J. 2019 Feb 21. pii: 5359476. doi: 10.1093.
    PubMed     Abstract available


    January 2019
  104. GOLDHABER SZ, Piazza G
    Fine-tuning the decision to initiate anticoagulation in atrial fibrillation by accounting for age and cardiovascular comorbidities.
    Eur Heart J. 2019 Jan 25. pii: 5301477. doi: 10.1093.
    PubMed    


  105. KHAN AA, Lip GYH
    Non-vitamin K antagonist oral anticoagulants beyond atrial fibrillation: what did we learn from COMPASS and COMMANDER-HF?
    Eur Heart J. 2019 Jan 21. pii: 5298544. doi: 10.1093.
    PubMed    


  106. BORIANI G, Ruff CT, Kuder JF, Shi M, et al
    Relationship between body mass index and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial.
    Eur Heart J. 2019 Jan 8. pii: 5280832. doi: 10.1093.
    PubMed     Abstract available


  107. KIM TH, Yang PS, Yu HT, Jang E, et al
    Effect of hypertension duration and blood pressure level on ischaemic stroke risk in atrial fibrillation: nationwide data covering the entire Korean population.
    Eur Heart J. 2019 Jan 4. pii: 5273478. doi: 10.1093.
    PubMed     Abstract available


  108. CHAO TF, Lip GYH, Lin YJ, Chang SL, et al
    Age threshold for the use of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation: insights into the optimal assessment of age and incident comorbidities.
    Eur Heart J. 2019 Jan 2. pii: 5272355. doi: 10.1093.
    PubMed     Abstract available


    December 2018
  109. ASAMI M, Windecker S, Praz F, Lanz J, et al
    Transcatheter aortic valve replacement in patients with concomitant mitral stenosis.
    Eur Heart J. 2018 Dec 28. pii: 5265291. doi: 10.1093.
    PubMed     Abstract available


  110. YU HT, Shim J, Park J, Kim TH, et al
    When is it appropriate to stop non-vitamin K antagonist oral anticoagulants before catheter ablation of atrial fibrillation? A multicentre prospective randomized study.
    Eur Heart J. 2018 Dec 27. pii: 5263768. doi: 10.1093.
    PubMed     Abstract available


  111. VLASTRA W, Chandrasekhar J, Munoz-Garcia AJ, Tchetche D, et al
    Comparison of balloon-expandable vs. self-expandable valves in patients undergoing transfemoral transcatheter aortic valve implantation: from the CENTER-collaboration.
    Eur Heart J. 2018 Dec 24. pii: 5259360. doi: 10.1093.
    PubMed     Abstract available


  112. SEEGER J, Kapadia SR, Kodali S, Linke A, et al
    Rate of peri-procedural stroke observed with cerebral embolic protection during transcatheter aortic valve replacement: a patient-level propensity-matched analysis.
    Eur Heart J. 2018 Dec 24. pii: 5259357. doi: 10.1093.
    PubMed     Abstract available


  113. CHAO TF, Chen SA, Ruff CT, Hamershock RA, et al
    Clinical outcomes, edoxaban concentration, and anti-factor Xa activity of Asian patients with atrial fibrillation compared with non-Asians in the ENGAGE AF-TIMI 48 trial.
    Eur Heart J. 2018 Dec 22. pii: 5258031. doi: 10.1093.
    PubMed     Abstract available


  114. WANG KL, Lopes RD, Patel MR, Buller HR, et al
    Efficacy and safety of reduced-dose non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a meta-analysis of randomized controlled trials.
    Eur Heart J. 2018 Dec 22. pii: 5255630. doi: 10.1093.
    PubMed     Abstract available


  115. KILLU AM, Granger CB, Gersh BJ
    Risk stratification for stroke in atrial fibrillation: a critique.
    Eur Heart J. 2018 Dec 1. pii: 5224504. doi: 10.1093.
    PubMed     Abstract available


    November 2018
  116. STEFFEL J, Potpara TS
    Challenges in clinical decision-making on concomitant drug therapies in patients with atrial fibrillation taking oral anticoagulants.
    Eur Heart J. 2018 Nov 29. pii: 5219661. doi: 10.1093.
    PubMed    


  117. SINNAEVE PR, Van de Werf F
    Endogenous fibrinolysis in STEMI: important before and after primary PCI.
    Eur Heart J. 2018 Nov 27. pii: 5211210. doi: 10.1093.
    PubMed    


    October 2018
  118. FARAG M, Spinthakis N, Gue YX, Srinivasan M, et al
    Impaired endogenous fibrinolysis in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention is a predictor of recurrent cardiovascular events: the RISK PPCI study.
    Eur Heart J. 2018 Oct 30. pii: 5149701. doi: 10.1093.
    PubMed     Abstract available


  119. YOON SH, Whisenant BK, Bleiziffer S, Delgado V, et al
    Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification.
    Eur Heart J. 2018 Oct 23. pii: 5143983. doi: 10.1093.
    PubMed     Abstract available


    September 2018
  120. SZUMMER K, Wallentin L, Lindhagen L, Alfredsson J, et al
    Relations between implementation of new treatments and improved outcomes in patients with non-ST-elevation myocardial infarction during the last 20 years: experiences from SWEDEHEART registry 1995 to 2014.
    Eur Heart J. 2018 Sep 19. pii: 5103432. doi: 10.1093.
    PubMed     Abstract available


  121. ALKHOULI M, Holmes DR
    Blaming the PFO in patients with cryptogenic ischaemic stroke: Round 2.
    Eur Heart J. 2018 Sep 9. pii: 5093358. doi: 10.1093.
    PubMed    


  122. FUJIMOTO D, Mochizuki Y, Nakagiri K, Shite J, et al
    Unusual rapid progression of non-bacterial thrombotic endocarditis in a patient with bladder cancer despite undergoing intensification treatment with rivaroxaban for acute venous thromboembolism.
    Eur Heart J. 2018 Sep 9. pii: 5093360. doi: 10.1093.
    PubMed    


    August 2018
  123. MENEVEAU N, Guillon B, Planquette B, Piton G, et al
    Outcomes after extracorporeal membrane oxygenation for the treatment of high-risk pulmonary embolism: a multicentre series of 52 cases.
    Eur Heart J. 2018 Aug 22. pii: 5078171. doi: 10.1093.
    PubMed     Abstract available


  124. SHAH R, Wilkins E, Nichols M, Kelly P, et al
    Epidemiology report: trends in sex-specific cerebrovascular disease mortality in Europe based on WHO mortality data.
    Eur Heart J. 2018 Aug 14. pii: 5069358. doi: 10.1093.
    PubMed     Abstract available


  125. FREEDMAN B
    Major progress in anticoagulant uptake for atrial fibrillation at last: does it translate into stroke prevention?
    Eur Heart J. 2018 Aug 10. pii: 5070412. doi: 10.1093.
    PubMed    


  126. SHEHATA N, Mistry N, da Costa BR, Pereira TV, et al
    Restrictive compared with liberal red cell transfusion strategies in cardiac surgery: a meta-analysis.
    Eur Heart J. 2018 Aug 10. pii: 5070413. doi: 10.1093.
    PubMed     Abstract available


  127. O'SHAUGHNESSY MM, Liu S, Montez-Rath ME, Lafayette RA, et al
    Cause of kidney disease and cardiovascular events in a national cohort of US patients with end-stage renal disease on dialysis: a retrospective analysis.
    Eur Heart J. 2018 Aug 2. pii: 5064050. doi: 10.1093.
    PubMed     Abstract available


    July 2018
  128. FRIEDRICH S, Ng PY, Platzbecker K, Burns SM, et al
    Patent foramen ovale and long-term risk of ischaemic stroke after surgery.
    Eur Heart J. 2018 Jul 17. pii: 5055460. doi: 10.1093.
    PubMed     Abstract available


  129. COWAN JC, Wu J, Hall M, Orlowski A, et al
    A 10 year study of hospitalized atrial fibrillation-related stroke in England and its association with uptake of oral anticoagulation.
    Eur Heart J. 2018 Jul 5. pii: 5049393. doi: 10.1093.
    PubMed     Abstract available


    June 2018
  130. RIDKER PM
    Interleukin-1 inhibition and ischaemic stroke: has the time for a major outcomes trial arrived?
    Eur Heart J. 2018 Jun 27. pii: 5046018. doi: 10.1093.
    PubMed    


  131. SIBBING D, Gross L, Trenk D, Jacobshagen C, et al
    Age and outcomes following guided de-escalation of antiplatelet treatment in acute coronary syndrome patients undergoing percutaneous coronary intervention: results from the randomized TROPICAL-ACS trial.
    Eur Heart J. 2018 Jun 14. pii: 5037998. doi: 10.1093.
    PubMed     Abstract available


    May 2018
  132. JANSSENS SP, Bogaert J, Zalewski J, Toth A, et al
    Nitric oxide for inhalation in ST-elevation myocardial infarction (NOMI): a multicentre, double-blind, randomized controlled trial.
    Eur Heart J. 2018 May 24. pii: 5003325. doi: 10.1093.
    PubMed     Abstract available


  133. YANG H, Nassif M, Khairy P, de Groot JR, et al
    Cardiac diagnostic work-up of ischaemic stroke.
    Eur Heart J. 2018;39:1851-1860.
    PubMed     Abstract available


  134. FRIEDMAN DJ, Granger CB
    Uninterrupted apixaban for atrial fibrillation ablation is a reasonable alternative, but what is the significance of silent cerebral infarctions?
    Eur Heart J. 2018 May 19. pii: 4999868. doi: 10.1093.
    PubMed    


  135. LIBERALE L, Diaz-Canestro C, Bonetti NR, Paneni F, et al
    Post-ischaemic administration of the murine Canakinumab-surrogate antibody improves outcome in experimental stroke.
    Eur Heart J. 2018 May 16. pii: 4996878. doi: 10.1093.
    PubMed     Abstract available


    April 2018
  136. FANAROFF AC, Steffel J, Alexander JH, Lip GYH, et al
    Stroke prevention in atrial fibrillation: re-defining 'real-world data' within the broader data universe.
    Eur Heart J. 2018 Apr 23. pii: 4982606. doi: 10.1093.
    PubMed     Abstract available


  137. MAHMOUD KD, Jolly SS, James S, Dzavik V, et al
    Clinical impact of direct stenting and interaction with thrombus aspiration in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: Thrombectomy Trialists Collaboration.
    Eur Heart J. 2018 Apr 21. pii: 4975836. doi: 10.1093.
    PubMed     Abstract available


  138. EZEKOWITZ MD, Pollack CV Jr, Halperin JL, England RD, et al
    Apixaban compared to heparin/vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: the EMANATE trial.
    Eur Heart J. 2018 Apr 6. pii: 4963487. doi: 10.1093.
    PubMed     Abstract available


  139. ANDREOTTI F, Navarese EP, Crea F
    Prolonged endogenous fibrinolysis predicts reduced survival after acute coronary syndromes.
    Eur Heart J. 2018;39:1086-1088.
    PubMed    


    March 2018
  140. LANDMESSER U, Chapman MJ, Stock JK, Amarenco P, et al
    New prospects for PCSK9 inhibition?
    Eur Heart J. 2018 Mar 22. pii: 4951530. doi: 10.1093.
    PubMed    


  141. KIRCHHOF P, Haeusler KG, Blank B, De Bono J, et al
    Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation.
    Eur Heart J. 2018 Mar 20. pii: 4943979. doi: 10.1093.
    PubMed     Abstract available


  142. STEFFEL J, Verhamme P, Potpara TS, Albaladejo P, et al
    The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.
    Eur Heart J. 2018 Mar 17. pii: 4942493. doi: 10.1093.
    PubMed     Abstract available


  143. AUFFRET V, Cottin Y, Leurent G, Gilard M, et al
    Predicting the development of in-hospital cardiogenic shock in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: the ORBI risk score.
    Eur Heart J. 2018 Mar 15. pii: 4938779. doi: 10.1093.
    PubMed     Abstract available


    February 2018
  144. FADINI GP, Cosentino F
    Diabetes and ischaemic stroke: a deadly association.
    Eur Heart J. 2018 Feb 9. pii: 4846897. doi: 10.1093.
    PubMed    


  145. ECHOUFFO-TCHEUGUI JB, Xu H, Matsouaka RA, Xian Y, et al
    Diabetes and long-term outcomes of ischaemic stroke: findings from Get With The Guidelines-Stroke.
    Eur Heart J. 2018 Feb 9. pii: 4846898. doi: 10.1093.
    PubMed     Abstract available


  146. LANCELLOTTI P, Galderisi M
    Prediction of ischaemic stroke in non-valvular atrial fibrillation if advanced echocardiography plays the game.
    Eur Heart J. 2018 Feb 9. pii: 4847811. doi: 10.1093.
    PubMed    


    January 2018
  147. BERGMARK BA, Scirica BM, Steg PG, Fanola CL, et al
    Blood pressure and cardiovascular outcomes in patients with diabetes and high cardiovascular risk.
    Eur Heart J. 2018 Jan 31. pii: 4831245. doi: 10.1093.
    PubMed     Abstract available


  148. MEHLUM MH, Liestol K, Kjeldsen SE, Julius S, et al
    Blood pressure variability and risk of cardiovascular events and death in patients with hypertension and different baseline risks.
    Eur Heart J. 2018 Jan 20. pii: 4815726. doi: 10.1093.
    PubMed     Abstract available


  149. MAHAJAN R, Perera T, Elliott AD, Twomey DJ, et al
    Subclinical device-detected atrial fibrillation and stroke risk: a systematic review and meta-analysis.
    Eur Heart J. 2018 Jan 10. pii: 4797540. doi: 10.1093.
    PubMed     Abstract available


  150. HEALEY JS
    The winding path towards rationale anti-thrombotic therapy to prevent stroke in patients with atrial fibrillation.
    Eur Heart J. 2018 Jan 9. pii: 4796907. doi: 10.1093.
    PubMed    


  151. LIP GYH, Lane DA, Potpara TS
    Innovative strategies to improve adherence to non-vitamin K antagonist oral anticoagulants for stroke prevention in atrial fibrillation.
    Eur Heart J. 2018 Jan 6. pii: 4791955. doi: 10.1093.
    PubMed    


  152. KIM K, Park SM, Lee K
    Weight gain after smoking cessation does not modify its protective effect on myocardial infarction and stroke: evidence from a cohort study of men.
    Eur Heart J. 2018 Jan 6. pii: 4791953. doi: 10.1093.
    PubMed     Abstract available


  153. DESTEGHE L, Vijgen J, Koopman P, Dilling-Boer D, et al
    Telemonitoring-based feedback improves adherence to non-vitamin K antagonist oral anticoagulants intake in patients with atrial fibrillation.
    Eur Heart J. 2018 Jan 2. pii: 4782504. doi: 10.1093.
    PubMed     Abstract available


    December 2017
  154. LEUNG M, van Rosendael PJ, Abou R, Ajmone Marsan N, et al
    Left atrial function to identify patients with atrial fibrillation at high risk of stroke: new insights from a large registry.
    Eur Heart J. 2017 Dec 28. pii: 4781364. doi: 10.1093.
    PubMed     Abstract available


  155. POKORNEY SD, Granger CB
    Traumatic injury: another unjustified reason to stop oral anticoagulation for atrial fibrillation.
    Eur Heart J. 2017 Dec 13. pii: 4735276. doi: 10.1093.
    PubMed    


    November 2017
  156. SPOSATO LA, Lopes RD
    Oral anticoagulation: a step toward solving the puzzle of dementia related to atrial fibrillation?
    Eur Heart J. 2017 Nov 27. pii: 4665696. doi: 10.1093.
    PubMed    


  157. DARMON A, Bhatt DL, Elbez Y, Aboyans V, et al
    External applicability of the COMPASS trial: an analysis of the reduction of atherothrombosis for continued health (REACH) registry.
    Eur Heart J. 2017 Nov 23. pii: 4656148. doi: 10.1093.
    PubMed     Abstract available


  158. STAERK L, Fosbol EL, Lamberts M, Bonde AN, et al
    Resumption of oral anticoagulation following traumatic injury and risk of stroke and bleeding in patients with atrial fibrillation: a nationwide cohort study.
    Eur Heart J. 2017 Nov 18. doi: 10.1093.
    PubMed     Abstract available


    October 2017
  159. KIM MK, Han K, Kim HS, Park YM, et al
    Cholesterol variability and the risk of mortality, myocardial infarction, and stroke: a nationwide population-based study.
    Eur Heart J. 2017 Oct 21. doi: 10.1093.
    PubMed     Abstract available


  160. LANDMESSER U, Chapman MJ, Stock JK, Amarenco P, et al
    2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia.
    Eur Heart J. 2017 Oct 16. doi: 10.1093.
    PubMed    


  161. CALIFF RM
    Finding ideal blood pressure targets in ischaemic stroke: prospective insight or retrospective guesswork?
    Eur Heart J. 2017;38:2836-2837.
    PubMed    


  162. BANGALORE S, Schwamm L, Smith EE, Hellkamp AS, et al
    Blood pressure and in-hospital outcomes in patients presenting with ischaemic stroke.
    Eur Heart J. 2017;38:2827-2835.
    PubMed     Abstract available


    September 2017
  163. KIVIMAKI M, Nyberg ST, Batty GD, Kawachi I, et al
    Long working hours as a risk factor for atrial fibrillation: a multi-cohort study.
    Eur Heart J. 2017;38:2621-2628.
    PubMed     Abstract available


    August 2017
  164. SZUMMER K, Wallentin L, Lindhagen L, Alfredsson J, et al
    Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014.
    Eur Heart J. 2017 Aug 29. doi: 10.1093.
    PubMed     Abstract available


  165. WIDIMSKY P, Doehner W, Diener HC, Van Gelder IC, et al
    The role of cardiologists in stroke prevention and treatment: position paper of the European Society of Cardiology Council on Stroke.
    Eur Heart J. 2017 Aug 28. doi: 10.1093.
    PubMed    


  166. IBANEZ B, James S, Agewall S, Antunes MJ, et al
    2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European S
    Eur Heart J. 2017 Aug 26. doi: 10.1093.
    PubMed    


  167. ABOYANS V, Bjorck M, Brodmann M, Collet JP, et al
    Questions and answers on diagnosis and management of patients with Peripheral Arterial Diseases: a companion document of the 2017 ESC Guidelines for the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Societ
    Eur Heart J. 2017 Aug 26. doi: 10.1093.
    PubMed    


    July 2017
  168. VRANCKX P, Windecker S, Welsh RC, Valgimigli M, et al
    Thrombo-embolic prevention after transcatheter aortic valve implantation.
    Eur Heart J. 2017 Jul 25. doi: 10.1093.
    PubMed     Abstract available


  169. HOPEWELL JC, Malik R, Valdes-Marquez E, Worrall BB, et al
    Differential effects of PCSK9 variants on risk of coronary disease and ischaemic stroke.
    Eur Heart J. 2017 Jul 17. doi: 10.1093.
    PubMed     Abstract available


    May 2017
  170. VIDAL-PETIOT E, Stebbins A, Chiswell K, Ardissino D, et al
    Visit-to-visit variability of blood pressure and cardiovascular outcomes in patients with stable coronary heart disease. Insights from the STABILITY trial.
    Eur Heart J. 2017 May 27. doi: 10.1093.
    PubMed     Abstract available


    April 2017
  171. SINGH-MANOUX A, Fayosse A, Sabia S, Canonico M, et al
    Atrial fibrillation as a risk factor for cognitive decline and dementia.
    Eur Heart J. 2017 Apr 29. doi: 10.1093.
    PubMed     Abstract available


  172. CAVALCANTE R, Sotomi Y, Mancone M, Whan Lee C, et al
    Impact of the SYNTAX scores I and II in patients with diabetes and multivessel coronary disease: a pooled analysis of patient level data from the SYNTAX, PRECOMBAT, and BEST trials.
    Eur Heart J. 2017 Apr 18. doi: 10.1093.
    PubMed     Abstract available


  173. VRANCKX P, Frigoli E, Rothenbuhler M, Tomassini F, et al
    Radial versus femoral access in patients with acute coronary syndromes with or without ST-segment elevation.
    Eur Heart J. 2017;38:1069-1080.
    PubMed     Abstract available


  174. PALMERINI T, Della Riva D, Benedetto U, Bacchi Reggiani L, et al
    Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients.
    Eur Heart J. 2017;38:1034-1043.
    PubMed     Abstract available


    March 2017
  175. RAHIMI K
    Subclinical atrial fibrillation in need of more assertive evidence.
    Eur Heart J. 2017 Mar 31. doi: 10.1093.
    PubMed    


  176. VOLLEMA EM, Kong WK, Katsanos S, Kamperidis V, et al
    Transcatheter aortic valve thrombosis: the relation between hypo-attenuated leaflet thickening, abnormal valve haemodynamics, and stroke.
    Eur Heart J. 2017 Mar 27. doi: 10.1093.
    PubMed     Abstract available


  177. RUILE P, Neumann FJ
    Hypo-attenuated leaflet thickening of transcatheter aortic valves: jeopardy or epiphenomenon?
    Eur Heart J. 2017 Mar 27. doi: 10.1093.
    PubMed    


  178. CAMM AJ, Savelieva I
    Female gender as a risk factor for stroke associated with atrial fibrillation.
    Eur Heart J. 2017 Mar 27. doi: 10.1093.
    PubMed    


  179. LI XS, Obeid S, Klingenberg R, Gencer B, et al
    Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors.
    Eur Heart J. 2017;38:814-824.
    PubMed     Abstract available


  180. ABDUL-RAHIM AH, Perez AC, MacIsaac RL, Jhund PS, et al
    Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials.
    Eur Heart J. 2017;38:742-750.
    PubMed     Abstract available


  181. VAN GELDER IC, Healey JS, Crijns HJ, Wang J, et al
    Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT.
    Eur Heart J. 2017 Mar 1. doi: 10.1093.
    PubMed     Abstract available


    February 2017
  182. PASEA L, Chung SC, Pujades-Rodriguez M, Moayyeri A, et al
    Personalising the decision for prolonged dual antiplatelet therapy: development, validation and potential impact of prognostic models for cardiovascular events and bleeding in myocardial infarction survivors.
    Eur Heart J. 2017 Feb 27. doi: 10.1093.
    PubMed     Abstract available


  183. MAZZOLAI L, Aboyans V, Ageno W, Agnelli G, et al
    Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European society of cardiology working groups of aorta and peripheral circulation and pulmonary circulation and right ventricular function.
    Eur Heart J. 2017 Feb 17. doi: 10.1093.
    PubMed    


  184. CIMATO TR
    Persistent stem cell-driven inflammation in patients with prior MI and stroke.
    Eur Heart J. 2017;38:433-435.
    PubMed    


    January 2017
  185. GADSBOLL K, Staerk L, Fosbol EL, Sindet-Pedersen C, et al
    Increased use of oral anticoagulants in patients with atrial fibrillation: temporal trends from 2005 to 2015 in Denmark.
    Eur Heart J. 2017 Jan 21. pii: ehw658. doi: 10.1093.
    PubMed     Abstract available


  186. RENOUX C, Coulombe J, Suissa S
    Revisiting sex differences in outcomes in non-valvular atrial fibrillation: a population-based cohort study.
    Eur Heart J. 2017 Jan 10. pii: ehw613. doi: 10.1093.
    PubMed     Abstract available


  187. REINER MF, Breitenstein A, Holy EW, Glanzmann M, et al
    Ticagrelor, but not clopidogrel active metabolite, displays antithrombotic properties in the left atrial endocardium.
    Eur Heart J. 2017 Jan 8. pii: ehw578. doi: 10.1093.
    PubMed     Abstract available


  188. FANOLA CL, Giugliano RP, Ruff CT, Trevisan M, et al
    A novel risk prediction score in atrial fibrillation for a net clinical outcome from the ENGAGE AF-TIMI 48 randomized clinical trial.
    Eur Heart J. 2017 Jan 6. pii: ehw565. doi: 10.1093.
    PubMed     Abstract available


  189. DE CARLO M, Mazzolai L, Bossone E, Brodmann M, et al
    The year in cardiology 2016: peripheral circulation.
    Eur Heart J. 2017 Jan 2. pii: ehw643. doi: 10.1093.
    PubMed    


  190. GAL P, Marrouche NF
    Magnetic resonance imaging of atrial fibrosis: redefining atrial fibrillation to a syndrome.
    Eur Heart J. 2017;38:14-19.
    PubMed     Abstract available


    November 2016
  191. YANG H, Nassif M, Khairy P, de Groot JR, et al
    Cardiac diagnostic work-up of ischaemic stroke.
    Eur Heart J. 2016.
    PubMed     Abstract available


    October 2016
  192. TARANTINI G, Mojoli M, Urena M, Vahanian A, et al
    Atrial fibrillation in patients undergoing transcatheter aortic valve implantation: epidemiology, timing, predictors, and outcome.
    Eur Heart J. 2016.
    PubMed     Abstract available


  193. GUDBJARTSSON DF, Holm H, Sulem P, Masson G, et al
    A frameshift deletion in the sarcomere gene MYL4 causes early-onset familial atrial fibrillation.
    Eur Heart J. 2016.
    PubMed     Abstract available


  194. STAERK L, Fosbol EL, Lip GY, Lamberts M, et al
    Ischaemic and haemorrhagic stroke associated with non-vitamin K antagonist oral anticoagulants and warfarin use in patients with atrial fibrillation: a nationwide cohort study.
    Eur Heart J. 2016.
    PubMed     Abstract available



  195. Racing against time in acute ischaemic stroke treatment.
    Eur Heart J. 2016;37:2856-2857.
    PubMed    


    September 2016
  196. PICCINI JP, Sievert H, Patel MR
    Left atrial appendage occlusion: rationale, evidence, devices, and patient selection.
    Eur Heart J. 2016.
    PubMed     Abstract available


    August 2016
  197. LUSCHER TF
    Atrial fibrillation and stroke: risk factors, anticoagulation, and left atrial appendage occluders.
    Eur Heart J. 2016;37:2443-5.
    PubMed    


    June 2016
  198. BASSAND JP, Accetta G, Camm AJ, Cools F, et al
    Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF.
    Eur Heart J. 2016.
    PubMed     Abstract available


  199. FERREIRA JP, Girerd N, Alshalash S, Konstam MA, et al
    Antithrombotic therapy in heart failure patients with and without atrial fibrillation: update and future challenges.
    Eur Heart J. 2016.
    PubMed     Abstract available


    April 2016
  200. SANDHU RK, Ezekowitz J, Andersson U, Alexander JH, et al
    The 'obesity paradox' in atrial fibrillation: observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial.
    Eur Heart J. 2016.
    PubMed     Abstract available


  201. NIELSEN JC, Gerdes JC
    Does catheter ablation reduce mortality and stroke in patients with atrial fibrillation? Patient selection or causality?
    Eur Heart J. 2016.
    PubMed    


    March 2016
  202. CAIRNS JA
    The search for the ideal atrial fibrillation stroke risk prediction schema: is ATRIA a contender?
    Eur Heart J. 2016.
    PubMed    


  203. LUSCHER TF, Sudano I
    SPRINT: the race for optimal blood pressure control.
    Eur Heart J. 2016;37:937-41.
    PubMed    


  204. FRIBERG L, Tabrizi F, Englund A
    Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death: data from Swedish health registries.
    Eur Heart J. 2016.
    PubMed     Abstract available


  205. FOX KA
    CardioPulse: Anticoagulants reduce risk of death in atrialfibrillation patients by 38%.
    Eur Heart J. 2016;37:860-1.
    PubMed    


  206. SVENSSON T, Inoue M, Sawada N, Yamagishi K, et al
    Coping strategies and risk of cardiovascular disease incidence and mortality: the Japan Public Health Center-based prospective Study.
    Eur Heart J. 2016;37:890-9.
    PubMed     Abstract available


  207. STOEKENBROEK RM, Boekholdt SM, Luben R, Hovingh GK, et al
    Heterogeneous impact of classic atherosclerotic risk factors on different arterial territories: the EPIC-Norfolk prospective population study.
    Eur Heart J. 2016;37:880-9.
    PubMed     Abstract available


  208. RANTHE MF, Diaz LJ, Behrens I, Bundgaard H, et al
    Association between pregnancy losses in women and risk of atherosclerotic disease in their relatives: a nationwide cohort studydagger.
    Eur Heart J. 2016;37:900-7.
    PubMed     Abstract available


  209. WAKSMAN R, Rogers T
    CardioPulse: Transcatheter aortic valve replacement.The American perspective on transcatheter aortic valve replacement.
    Eur Heart J. 2016;37:797-9.
    PubMed    


  210. ASPBERG S, Chang Y, Atterman A, Bottai M, et al
    Comparison of the ATRIA, CHADS2, and CHA2DS2-VASc stroke risk scores in predicting ischaemic stroke in a large Swedish cohort of patients with atrial fibrillation.
    Eur Heart J. 2016.
    PubMed     Abstract available


    February 2016
  211. HIJAZI Z, Lindback J, Alexander JH, Hanna M, et al
    The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation.
    Eur Heart J. 2016.
    PubMed     Abstract available


  212. GANESAN AN, Chew DP, Hartshorne T, Selvanayagam JB, et al
    The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding: a systematic review and meta-analysis.
    Eur Heart J. 2016.
    PubMed     Abstract available


  213. TRUCHANOWICZ E, Kirchhof P
    CardioPulse: New perspectives for stroke prevention in atrial fibrillation.
    Eur Heart J. 2016;37:583-4.
    PubMed    


  214. STEFFEL J, Jais P, Hindricks G
    The year in cardiology 2015: arrhythmias and device therapy.
    Eur Heart J. 2016;37:587-93.
    PubMed    


  215. DIENER HC, Aisenberg J, Ansell J, Atar D, et al
    Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2.
    Eur Heart J. 2016.
    PubMed     Abstract available


  216. DIENER HC, Aisenberg J, Ansell J, Atar D, et al
    Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1.
    Eur Heart J. 2016.
    PubMed     Abstract available


    January 2016
  217. IUNG B, Rahimtoola SH, Vahanian A
    The year in cardiology 2015: valvular heart disease.
    Eur Heart J. 2016.
    PubMed    


    November 2015
  218. MANCIA G, Kjeldsen SE, Zappe DH, Holzhauer B, et al
    Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trial.
    Eur Heart J. 2015.
    PubMed     Abstract available


  219. HAMM CW, Arsalan M, Mack MJ
    The future of transcatheter aortic valve implantation.
    Eur Heart J. 2015.
    PubMed     Abstract available


    September 2015
  220. O'BRIEN EC, Simon DN, Thomas LE, Hylek EM, et al
    The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation.
    Eur Heart J. 2015.
    PubMed     Abstract available


  221. KOTECHA D, Piccini JP
    Atrial fibrillation in heart failure: what should we do?
    Eur Heart J. 2015.
    PubMed     Abstract available


  222. SKOLOUDIK D, Kuliha M, Hrbac T, Jonszta T, et al
    Sonolysis in Prevention of Brain Infarction During Carotid Endarterectomy and Stenting (SONOBUSTER): a randomized, controlled trial.
    Eur Heart J. 2015.
    PubMed     Abstract available


  223. VINEREANU D, Stevens SR, Alexander JH, Al-Khatib SM, et al
    Clinical outcomes in patients with atrial fibrillation according to sex during anticoagulation with apixaban or warfarin: a secondary analysis of a randomized controlled trial.
    Eur Heart J. 2015.
    PubMed     Abstract available


    August 2015
  224. BARBASH IM, Barbanti M, Webb J, Molina-Martin De Nicolas J, et al
    Comparison of vascular closure devices for access site closure after transfemoral aortic valve implantation.
    Eur Heart J. 2015.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Stroke is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: